Tirzepatide/B12 Injectable (68mg/8mg)
US$ 26.72
retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Agonism Based Therapies for Retatrutide vs. Tirzepatide: The Next-Gen
Description
doi: 10.1016/j.brainresbull.2020.11.008 80 NikolaidisLAMankadSSokosGGMiskeGShahAElahiDet al
PMID 15090972
Recently recognized as a disease by the American Medical Association and other medical societies, obesity has grown in prevalence in the United States and around the world
The RR is lowest at 3 months 0.43 (95% CI: 0.28, 0.67
miR-7 Regulates GLP-1-Mediated Insulin Release by Targeting -Arrestin 1
Given that retatrutide likely causes similar or greater gastroparesis than tirzepatide, the same oral absorption concerns would apply
